{"entity":{"type":"insider","cik":"0001697644","url":"/insider/0001697644","json_url":"/insider/0001697644.json","name":"Kutok Jeffery","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2018-06-25","last":"2022-04-13","span_basis":"filed_date"},"name_variants":[{"name":"Kutok Jeffery","source":"filing","n_filings":5,"first_seen":"2018-06-25","last_seen":"2022-04-13"}],"transactions":[{"id":6471592,"accession":"0000899243-22-014724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014724","line_url":"/filing/0000899243-22-014724#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2741.0,"shares_display":"2,741","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":2466.9,"total_display":"2,466.90","shares_owned_after":94563.0,"shares_owned_after_display":"94,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider"},{"id":6087691,"accession":"0000899243-22-004827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-004827","line_url":"/filing/0000899243-22-004827#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2556.0,"shares_display":"2,556","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":3501.72,"total_display":"3,501.72","shares_owned_after":97304.0,"shares_owned_after_display":"97,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":5276108,"accession":"0000899243-21-015175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-015175","line_url":"/filing/0000899243-21-015175#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock, par value $0.0","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2029.0,"shares_display":"2,029","price_per_share":8.8,"price_display":"8.80","price_state":"stated","total_value":17855.2,"total_display":"17,855.20","shares_owned_after":54028.0,"shares_owned_after_display":"54,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":6217249,"accession":"0000899243-18-022697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-022697","line_url":"/filing/0000899243-18-022697#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6133.0,"shares_display":"6,133","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":12266.0,"total_display":"12,266.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":6217238,"accession":"0000899243-18-022697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-022697","line_url":"/filing/0000899243-18-022697#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8180.0,"shares_display":"8,180","price_per_share":2.0074,"price_display":"2.01","price_state":"stated","total_value":16420.532,"total_display":"16,420.53","shares_owned_after":6133.0,"shares_owned_after_display":"6,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-17","scope":"insider"},{"id":6678149,"accession":"0000899243-18-017943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-017943","line_url":"/filing/0000899243-18-017943#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001697644","owner_name":"Kutok Jeffery","owner_url":"/insider/0001697644","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14313.0,"shares_display":"14,313","price_per_share":2.0048,"price_display":"2.00","price_state":"stated","total_value":28694.7024,"total_display":"28,694.70","shares_owned_after":14313.0,"shares_owned_after_display":"14,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-25","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (Chief Scientific Officer)","n_filings":3,"first_seen":"2021-04-07","last_seen":"2022-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001113148","name":"INFINITY PHARMACEUTICALS, INC.","url":"/issuer/0001113148","role":"Officer (Chief Scientific Officer)","n_filings":2,"first_seen":"2018-06-25","last_seen":"2018-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697644","retrieved_at":"2026-08-21T03:40:18+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}